Registry of Cardiovascular Disease Patients (CVD Registry)

December 27, 2012 updated by: Maccabi Healthcare Services, Israel

Computerized Registry of Cardiovascular Disease Patients

A computerized registry of cardiovascular disease patients in a large health maintenance organization in Israel. The registry is aimed to be used by health professionals to identify cardiovascular disease patients and to follow the courses of their illnesses and risk factors.

Study Overview

Status

Enrolling by invitation

Conditions

Detailed Description

The registry was initiated in 1998 by Maccabi Healthcare services, which is the second largest publicly funded HMO in Israel,serving 24% of the total population with a nationwide distribution.

The registry uses advanced information technology that integrates personal computerized community and hospital records, data from laboratory tests, dispensed medications, physiological signals, radiological images, and reports from investigations and procedures.

Study Type

Observational

Enrollment (Anticipated)

110000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Israel
      • Tel Aviv, Israel, 68125
        • Maccabi Healthcare Services

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The electronic registry includes all patients that had been diagnosed twice or more by hospital or outpatient cardiologists, primary physicians, or pediatricians with at least one of the following clinical diagnoses, classified according to the International Classification of Diseases, Ninth revision (ICD-9) codes: Ischemic Heart Disease,MI,non-MI,congestive heart failure,peripheral vascular disease, cerebrovascular disease CVA,TIA, Patients with prior coronary artery bypass grafting(CABG) or percutaneous coronary intervention (PCI), using relevant Current Procedural Terminology (CPT) codes were also included in the registry.

Description

Inclusion Criteria:

  • Clinical Diagnosis of the following:

Ischemic Heart Disease,MI,non-MI,congestive heart failure,peripheral vascular disease, cerebrovascular disease CVA,TIA,patients with first AMI diagnosis from community physicians if they were hospitalized for lasting at least 3 days during a 30-day period prior to diagnosis.

  • Patients with prior coronary artery bypass grafting(CABG) or percutaneous coronary intervention (PCI), using relevant Current Procedural Terminology (CPT) codes

Exclusion Criteria:

  • patients who were diagnosed as suffering from CHD by primary physician or general hospitals prior to 2000 with no further indication
  • Patients whose primary physician reported that the patient is CHD-free providing adequate medical records

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Cardiovascular Disease Patients

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number of Patients with Cardiovascular disease
Time Frame: Up to 100 years
Up to 100 years

Secondary Outcome Measures

Outcome Measure
Time Frame
prevalence rates of CVD
Time Frame: up to 100 years
up to 100 years
Major Adverse Cardiac Events
Time Frame: up to 100 years
up to 100 years
Number of LDL Tests performed reaching target LDL
Time Frame: up to 100 years
up to 100 years
Proportion of dyslipidemia patients treated with Statins
Time Frame: up to 100 years
up to 100 years

Other Outcome Measures

Outcome Measure
Time Frame
hospitalization days due to CVD
Time Frame: up to 100 years
up to 100 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Maccabi Healthcare Services, Israel

Investigators

  • Study Director: Gabriel Chodick, PHD, Head,Epidemiology & Database Reseaech Unit, Medical Division, Maccabi H.S

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 1998

Primary Completion (Anticipated)

December 1, 2100

Study Registration Dates

First Submitted

December 18, 2012

First Submitted That Met QC Criteria

December 27, 2012

First Posted (Estimate)

January 3, 2013

Study Record Updates

Last Update Posted (Estimate)

January 3, 2013

Last Update Submitted That Met QC Criteria

December 27, 2012

Last Verified

December 1, 2012

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • MACCVREG1
  • cvdregistry (Registry Identifier: Cardiovascular Disease Patients)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Atrial Fibrillation

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Georgia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe